Qu'est-ce (qui) est C-Met inhibitor - définition
C-Met inhibitor
![[[Tivantinib]] (ARQ197), a c-Met inhibitor](https://commons.wikimedia.org/wiki/Special:FilePath/Tivantinib.svg?width=200 "[[Tivantinib]] (ARQ197), a c-Met inhibitor")
CLASS OF COMPOUNDS
Discovery and development of small molecule c-Met inhibitors; C-Met inhibitors; MET inhibitor
c-Met inhibitors are a class of small molecules that inhibit the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF). These inhibitors may have therapeutic application in the treatment of various types of cancers.
C-Met
MAMMALIAN PROTEIN FOUND IN HOMO SAPIENS
Proto-oncogene proteins c-met; HGFR; C-MET; Hgfr; RCCP2; Rccp2; Met proto-oncogene; Hepatocyte growth factor receptor; MET (gene); MET kinase
c-Met, also called tyrosine-protein kinase Met or hepatocyte growth factor receptor (HGFR), is a protein that in humans is encoded by the MET gene. The protein possesses tyrosine kinase activity.
Polymerisation inhibitor
CHEMICAL ADDITIVE THAT SUPPRESSES POLYMERIZATION
Polymerization inhibitor
Polymerisation inhibitors (US: polymerization inhibitors) are chemical compounds added to monomers to prevent their auto-polymerisation. Unsaturated monomers such as acrylates, vinyl chloride, butadiene and styrene require inhibitors for both processing and safe transport and storage.
